Patients with Neovascular Age-Related Macular Degeneration Requiring Intensive Intravitreal Aflibercept Treatment: An ARIES Post Hoc Analysis.

MLA

Wolf, Sebastian, et al. “Patients with Neovascular Age-Related Macular Degeneration Requiring Intensive Intravitreal Aflibercept Treatment: An ARIES Post Hoc Analysis.” Ophthalmology and Therapy, vol. 11, no. 5, Oct. 2022, pp. 1793–803. EBSCOhost, https://doi.org/10.1007/s40123-022-00541-8.

APA

Wolf, S., Holz, F. G., Midena, E., Souied, E. H., Lambrou, G., Machewitz, T., Allmeier, H., & Mitchell, P. (2022). Patients with Neovascular Age-Related Macular Degeneration Requiring Intensive Intravitreal Aflibercept Treatment: An ARIES Post Hoc Analysis. Ophthalmology and Therapy, 11(5), 1793–1803. https://doi.org/10.1007/s40123-022-00541-8

Chicago

Wolf, Sebastian, Frank G Holz, Edoardo Midena, Eric H Souied, George Lambrou, Tobias Machewitz, Helmut Allmeier, and Paul Mitchell. 2022. “Patients with Neovascular Age-Related Macular Degeneration Requiring Intensive Intravitreal Aflibercept Treatment: An ARIES Post Hoc Analysis.” Ophthalmology and Therapy 11 (5): 1793–1803. doi:10.1007/s40123-022-00541-8.